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Investigating the impact of poverty on
colonization and infection with drug-
resistant organisms in humans: a
systematic review
Vivian Alividza1†, Victor Mariano1†, Raheelah Ahmad1,2, Esmita Charani1, Timothy M. Rawson1, Alison H. Holmes1
and Enrique Castro-Sánchez1*
Abstract
Background: Poverty increases the risk of contracting infectious diseases and therefore exposure to antibiotics. Yet
there is lacking evidence on the relationship between income and non-income dimensions of poverty and
antimicrobial resistance. Investigating such relationship would strengthen antimicrobial stewardship interventions.
Methods: A systematic review was conducted following Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines. PubMed, Ovid, MEDLINE, EMBASE, Scopus, CINAHL, PsychINFO,
EBSCO, HMIC, and Web of Science databases were searched in October 2016. Prospective and retrospective
studies reporting on income or non-income dimensions of poverty and their influence on colonisation or
infection with antimicrobial-resistant organisms were retrieved. Study quality was assessed with the Integrated quality
criteria for review of multiple study designs (ICROMS) tool.
Results: Nineteen articles were reviewed. Crowding and homelessness were associated with antimicrobial resistance in
community and hospital patients. In high-income countries, low income was associated with Streptococcus pneumoniae
and Acinetobacter baumannii resistance and a seven-fold higher infection rate. In low-income countries the findings on
this relation were contradictory. Lack of education was linked to resistant S. pneumoniae and Escherichia coli. Two papers
explored the relation between water and sanitation and antimicrobial resistance in low-income settings.
Conclusions: Despite methodological limitations, the results suggest that addressing social determinants of poverty
worldwide remains a crucial yet neglected step towards preventing antimicrobial resistance.
Keywords: Poverty, Antimicrobial stewardship, Drug resistance
Multilingual abstract
Please see Additional file 1 for translations of the ab-
stract into the five official working languages of the
United Nations.
Background
Poverty, or “the pronounced deprivation of well-being”,
still affected an estimated 767 million people worldwide
in 2013 despite remarkable efforts [1]. Such deprivation
can refer to income (i.e., low individual or household in-
come) and non-income dimensions such as limited
education, unemployment or precarious employment,
inadequate housing conditions, insufficient access to
healthcare, clean water and sanitation [2, 3]. The reductions
in income poverty achieved by the Millennium Develop-
ment Goals (MDGs) have however not been coupled with
significant improvements in other non-income dimensions.
Poverty greatly increases the risk of contracting in-
fectious diseases, with clinical outcomes further ag-
gravated by lacking access to healthcare. Poor waste
and sanitation, non-potable drinking water, housing
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overcrowding [4] and inadequate nutrition [5] are all
linked to risk of and recovery from infectious dis-
eases. Furthermore, the interconnection between the
different dimensions of poverty with infectious dis-
eases across countries with varying economic status
has also been well established [6–9].
In this context, addressing the leading global public
health threat of antimicrobial resistance (AMR) is critical
as it is invariably connected to infectious diseases, but also
a major threat to achievement of the sustainability goals.
In the last decade, global consumption of antibiotics in
human health increased by 40%, primarily in emerging
economies [10, 11]. Inappropriate use of antibiotics facili-
tated by unrestricted access without prescription in many
countries [12], self-medicating practices [13], or using old
and leftover antibiotics for a new health problem [14] fur-
ther exacerbates AMR. The scale of AMR-attributable
mortality is estimated at ~ 700 000 deaths per year world-
wide [15] and raises issues particularly relevant to the
most vulnerable citizens in society when achieving balance
of ‘excess’ versus ‘access’ to antibiotic treatment [16].
The association between different dimensions of pov-
erty and antibiotic exposure is not limited to low- and
middle-income countries (LMICs). In Sweden, experi-
ences of economic stress and low educational level in-
creased the odds of taking antibiotics [17], and in the
United Kingdom (UK), higher antibiotic prescribing
rates in primary care have been observed in deprived
areas [18, 19]. Several studies have shown increased anti-
biotic use among high socio-economic groups, particu-
larly in countries where private health insurance is the
norm [20]. Thus, the evidence on the link between pov-
erty and antimicrobial exposure, and subsequent AMR
remains unclear.
However, there is lack of evidence illustrating the re-
lationship between the dimensions of poverty and the
prevalence of AMR. Identifying poverty-related factors as-
sociated with antimicrobial resistant infections would in-
form policies beyond inappropriate antimicrobial use and
targeting interventions aimed at high risk groups, helping
policymakers allocate resources to address dimensions of
poverty that influence AMR. Such approach would have
the potential for benefit not only on individual and public
level health outcomes – but also from the economic per-
spective of the health system and societal level.
This paper investigates the association of AMR and pov-
erty by identifying the dimensions of poverty that are po-
tential factors in the acquisition of antimicrobial-resistant
organisms in humans.
Methods
Search strategy
This systematic review followed the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [21]. We searched the PubMed, Ovid, MEDLINE,
EMBASE, Scopus, CINAHL, PsychINFO, EBSCO, HMIC,
and Web of Science databases in October 2016. No date
limits were placed on the published articles. Search strings
were tailored to each database. Where Medical Subject
Headings (MeSH) terms and EMBASE headings were ap-
plicable, the main root of the term was used. Combina-
tions of the following search terms were used: “poverty”,
“socioeconomic factor”, “socioeconomic status”, “income”,
“antimicrobial resistance”, “antibiotic resistance”, “antiviral
resistance”, “antifungal resistance”, “housing”, “residence
characteristics”, “living conditions”, “educational status”,
“health literacy”, “employment”. Terms where truncated
as necessary.
Inclusion and exclusion criteria
We included prospective and retrospective studies that
reported on income or non-income dimensions of pov-
erty as variables and their influence on the acquisition of
antimicrobial-resistant organisms. Cohort, case-control,
and cross-sectional studies were included. We consid-
ered colonization and infection on any anatomical site
and organ system, among all age groups in any country.
We included all published literature written or translated
in English, except ecological studies, reviews, commen-
taries, and editorials.
Studies that used surrogates for antimicrobial resist-
ance such as antimicrobial consumption, dispensing and
prescribing were excluded. We also excluded studies ex-
clusively exploring the relationship between poverty and
HIV, tuberculosis and malaria, as reviews on these areas
have already been published [22]. These studies generally
explored the impact of poverty on non-adherence to
antiretroviral therapy, the financial burden of complying
with treatment, or the link between a single dimension
of poverty such as educational attainment or housing
conditions and the acquisition of these infections.
Study screening and selection
Study screening and selection was aided by software
Rayan (https://rayyan.qcri.org/) (Fig. 1). Two researchers
(VM & VA) independently and concurrently screened
each title and abstract, with any discrepancies about the
inclusion/exclusion of articles mediated by a third re-
searcher (ECS).
Data extraction
A standardised electronic data extraction form was com-
pleted with pertinent information from each source. The
following data were extracted: country of study, type of
study, study population, sample size, dimension of pov-
erty, measurement level of poverty, type of resistance
and organism, colonization or infection reported, and
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the association between the dimensions of poverty re-
ferred in the study to AMR.
Study quality assessment
The integrated quality criteria for review of multiple
study designs (ICROMS) [23] was used to conduct qual-
ity assessment of the papers selected. ICROMS is a com-
prehensive and practical tool in appraising a range of
studies to be included in systematic reviews, particularly
public health-related studies. The tool outlines the qual-
ity criteria specific to a study design and it determines
the robustness and the relevance of the study to the re-
view question using a decision matrix and scoring sys-
tem. As recommended, studies were not excluded based
on their appraised quality.
Categorisation of studies according to poverty
dimensions
The studies selected were grouped around the following
dimensions of poverty: a) housing and living conditions,
b) income and income inequality, c) education level, d)
water and sanitation and e) social deprivation.
Results
Due to the heterogeneity of settings, populations and
dimensions of poverty explored, the results are re-
ported in narrative format. Table 1 shows the
summary of studies discussed, including their
ICROMS scores. Of the 1464 articles retrieved, we
excluded 1371, full-text screened 55 and finally in-
cluded 19 in the review. The included studies were
published mainly in infectious diseases, microbiology,
and epidemiology journals, with a number of articles
from general medical and other non-infectious dis-
ease specialist sources. Included articles were pub-
lished from 1998 to 2015. Twelve studies were
conducted in high-income countries (HICs), predom-
inantly in the United States of America (USA)
followed by the UK.
Housing and living conditions
Crowding, homelessness, and living environment
have been associated with antimicrobial resistant
isolates in individuals in the community as well as
hospital patients (Table 2). 3995 community resi-
dents and hospital patients were enrolled between
Fig. 1 Study flowchart
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Table 1 Identified studies, by dimension of poverty and setting
Low-and middle-income countries Dimension of poverty High income countries
Association with antimicrobial resistance Association with antimicrobial resistance
Negative Positive Positive Negative
Duerink 2007 (Indonesia) [31]
Seidman 2009 (India) [36]
Kristiansson 2009 (Peru) [37]
Lestari 2010 (Indonesia)
[24]
Housing and living conditions Young 2004 (USA) [26]
Bratu 2006 (USA) [56]
Jourdain 2010 (Belgium)
[44]
Nilsson 2005 (Sweden)
[25]
Duerink 2007 (Indonesia) [31] Lestari 2010 (Indonesia)
[24]
Income and income
inequality
Chen 1998 (USA) [27]
McMullen 2009 (USA) [28]
Henig 2015 (Israel) [29]
No studies found
Duerink 2007 (Indonesia) [31]
Seidman 2009 (India) [36]
Kristiansson 2009 (Peru) [37]
Boyanova 2009 (Bulgaria)
[38]
Trecker 2014 (China) [32] Education level Huang 2004 (USA) [33]
Garcia-Rey 2004 (Spain) [34]
Nilsson 2005 (Sweden)
[25]
No studies found Seidman 2009 (India) [36]
Souza 2009 (Brazil) [39]
Water and Sanitation No studies found No studies found
No studies found No studies found Social depriation Bagger 2004 (UK) [40]
Nomamiukor 2015 (UK) [35]
Parsons 2001 (UK) [41]
Table 2 Studies identified exploring relation between antimicrobial resistance, housing and living conditions
Authors
and year
Country Study design Participants Population Measurement
level of poverty
Microorganism Colonisation
/ infection
Association
with AMR
ICROMS
score
Jourdain
et al.
2010
Belgium Cohort 1347 Healthy children
from 11 pre-
schools in Brussels
Household Resistant
Streptococcus
pneumoniae
Colonisation Positive 20
Lestari
et al.
2010 [24]
Indonesia Cohort 3995 Patients from 2
hospitals and 3
primary health
centres in 2 cities
in Java
Household Resistant
Staphylococcus
aureus
Colonisation Positive 24
Duerink
et al.
2007 [31]
Indonesia Retrospective
data analysis
3275 Patients from 2
hospitals and 3
primary health
centres in 2 cities
in Java
Household Resistant
Escherichia coli
Colonisation Negative Not
applicable
Bratu
et al.
2006 [56]
USA Cohort 1316 Patients from 15
hospitals in
Brooklyn, New York
Community/
Neighbourhood
(provincial-wide);
official census
data
Community-
Associated
MRSA
Not
specified
Positive 18
Nilsson
and Laurell
2005
Swede Retrospective
data analysis
766 Residents from
Malmö
Community/
Neighbourhood
(city-wide)
Penicillin non-
susceptible
Streptococcus
pneumoniae
Not
specified
Negative Not
Applicable
Bagger
et al.
2004 [44]
UK Cohort 1739 UK residents
undergoing
isolated coronary
artery bypass graft
in London
Community/
Neighbourhood
MRSA Infection Positive 21
Young
et al.
2004 [26]
USA Retrospective
data analysis
837 Patients from 1
specialist clinic in
San Francisco
Community/
Neighbourhood
MRSA Infection Positive Not
Applicable
Parsons
et al.
2001 [41]
UK Cohort 1064 Patients from 1
hospital in Sheffield
Community/
Neighbourhood
Resistant
Helicobacter
pylori
Not
specified
Negative 17
ICROMS Integrated quality criteria for review of multiple study designs, MRSA Methicillin-resistant Staphylococcus aureus
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2001 and 2002 in a study in Indonesia to determine
nasal carriage of Staphylococcus aureus and determi-
nants of such carriage, including demographic, socio-
economic, health and antimicrobial exposure
variables [24]. The carriage prevalence was 9.1%
(362/3995), and overcrowding (defined as households
with more than eight persons) was positively associ-
ated with carriage (OR = 4.5, 95% CI: 1.4–15.1) in
the community.
Nilsson et al. [25] estimated the relation between
penicillin-non-susceptible Streptococcus pneumoniae
(defined by the authors as MIC ≥0.5 mg/ml for penicil-
lin) and socio-economic factors including household
crowding in 19 residential areas in Malmo, Sweden. The
incidence of PNSP cases was not associated to any of
the socioeconomic variables and only with antibiotic
prescribing (r = 0.614, P < 0.01).
In the USA, lack of housing or homelessness was iden-
tified as a risk factor for methicillin-resistant S. aureus
(MRSA) infection in medically underserved patients with
soft tissue infections in a retrospective analysis con-
ducted in 2004 [26]. This review of attendees to a spe-
cialised center in San Francisco, California included
more than 7700 surgical procedures over 3 years. A sub-
analysis of the first 666 patients with positive S. aureus
and MRSA culture suggested that transmission of
infection was reported to occur in the community, with
MRSA associated with injection drug use (OR = 1.8;
P = 0.003) and homelessness (OR = 1.5; P = 0.03).
Income and income inequality
Evidence on the relationship between low income and
antimicrobial resistance in HICs has evolved (Table 3).
In 1998, Chen et al. reported a negative association be-
tween income and S. pneumoniae resistance in the USA,
using population-based surveillance for invasive
pneumococcal disease linked with neighbourhood-level
censal data such as age, race and address [27]. The asso-
ciation, however, seemed to exist only amongst Cauca-
sians and not African-American citizens.
More recent evidence in the same country established
a link between MRSA infection and low income [28].
The median income of the postcode of each person with
infection was used as a proxy, with low income defined
as a median annual income below 25 000 USD. The au-
thors however acknowledged that such categorisation of
income was a limitation.
In Israel, individuals with low socioeconomic status
had almost twice the risk of carbapenem-resistant
Acinetobacter baumannii (CRAB) colonisation and
bacteraemia compared to counterparts in high socio-
economic strata (OR = 2.18, 95% CI: 1.02–5). The
population-based case-control study conducted be-
tween 2007 and 2012 matched 1190 hospital patients
with CRAB and compared them to other 1190 hospi-
tals patients without Acinetobacter infection but
similar risk factors [29]. However, socioeconomic
status in this investigation was not exclusively re-
lated to income but also based on the patient’s
Table 3 Studies identified exploring relation between antimicrobial resistance, income and income inequality
Authors and
year
Country Study design Participants Population Measurement
level of
poverty
Microorganism Colonisation
/infection
Association
with AMR
ICROMS
score
Henig
et al. 2015
[29]
Israel Matched
Case-Control
Study
6998 Patients at largest
heath maintenance
organisation in Israel
Community Carbapenem-
resistant
Acinetobacter
baumannii
Both Positive Not
applicable
Lestari
et al. 2010
[24]
Indonesia Cohort 3995 Patients from 2
hospitals and 3
primary health centres
in 2 cities in Java
Household Resistant
Staphylococcus
aureus
Colonisation Positive 24
McMullen
et al. 2009
[28]
USA Retrospective
data analysis
10 530 Adult patients from
hospital in St. Louis
Community Community-
Associated
MRSA
Not
specified
Positive Not
applicable
Duerink
et al. 2007
[31]
Indonesia Retrospective
data analysis
3275 Patients from 2
hospitals and 3
primary health centres
in 2 cities in Java
Household Resistant
Escherichia coli
Colonisation Negative Not
applicable
Chen
et al. 1998
[27]
USA Retrospective
data analysis
716 Isolates from 33
laboratories in Atlanta,
Georgia
Community Drug-resistant
invasive
pneumococcal
infections
Infection Negative Not
applicable
Trecker
et al. 2014
[32]
China Cross-
sectional
384 Patients from hospital
in Shanghai
Individual Resistant
Neisseria
gonorrheae
Infection Positive Not
applicable
AMR Antimicrobial resistance, ICROMS Integrated quality criteria for review of multiple study designs, MRSA Methicillin-resistant Staphylococcus aureus
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outpatient clinic affiliation. In Israel, such affiliation
determines the type of healthcare coverage received
[30], which may be indicative of income. The
authors explained their results by either healthcare
access disparities including healthcare coverage or by
patients’ characteristics.
The relationship between income and antimicrobial-
resistant infections in LMICs presents more challenges.
Unlike evidence from HICs that generally included in-
come as a single variable, researchers from LMICs fre-
quently reported it bundled with and at least one other
dimension of poverty. Two Indonesian studies presented
contradictory associations between income and AMR.
Duerink et al. [31] did not find any association between
low income and Escherichia coli resistance, whilst other
researchers [24] suggested that low income was a deter-
minant factor for the carriage of MRSA. Both studies
had the same population of interest and classified in-
come level as either below or above the poverty line.
In China, males in the lowest income category were
more likely have antibiotic-resistant Neisseria gonorrhoea
compared with other individuals in the middle-income
category [32]. However, the findings in this study were
limited by the small sample size and the limited choice
of variables included in the multilevel regression model.
Education level
In HICs, lack of education seems positively associated
with the acquisition of resistant infections (Table 4). In
the USA, low parental educational attainment
Table 4 Studies identified exploring relation between antimicrobial resistance and education level
Authors and
year
Country Study design Participants Population Measurement
level of
poverty
Microorganism Colonisation
/infection
Association
with AMR
ICROMS
score
Nomamiukor
et al. 2015
[35]
UK Retrospective
data analysis
2775 Primary healthcare
patients in 2 cities
in Northwest
England
Community Resistant
Escherichia coli
Not
specified
Positive Not
applicable
Trecker et al.
2014 [32]
China Cross-
sectional
384 Patients from
hospital in
Shanghai
Individual Resistant
Neisseria
gonorrheae
Infection Positive Not
applicable
Boyanova
et al. 2009
[38]
Bulgaria Cohort 266 Untreated
Helicobacter pylori
patients from 4
hospitals in Sofia
Individual Resistant
H. pylori
Not
specified
Negative 19
Kristiansson
et al. 2009
[37]
Peru Cross-
sectional
nearly 1600 2 rural communities
in Amazonian Peru
Household Resistant
E. coli
Not
specified
Negative Not
applicable
Seidman
et al. 2009 [6]
India Cross-
sectional
120 2 rural villages in
Tamil Nadu
Household Resistant
E. coli
Colonisation Positive Not
applicable
Duerink et al.
2007 [31]
Indonesia Retrospective
data analysis
3275 Patients from 2
hospitals and 3
primary health
centres in 2 cities in
Java
Household Resistant
E. coli
Colonisation Negative Not
applicable
Nilsson and
Laurell 2005
Sweden Retrospective
data analysis
766 Residents from
Malmö
Community Penicillin non-
susceptible
Streptococcus
pneumoniae
Not
specified
Negative Not
applicable
Garcia-Rey
et al. 2004
[34]
Spain Retrospective
data analysis
2726 Isolates from
laboratories from 15
provinces in Spain;
Official provincial
population
demographic data
from the National
Statistics System
Community Resistant
S. pneumoniae
Not
specified
Positive Not
applicable
Huang et al.
2004 [33]
USA Cohort study 742 Young children
from 16
Massachusetts
communities
Community Resistant
S. pneumoniae
Both Positive 20
AMR Antimicrobial resistance, ICROMS Integrated quality criteria for review of multiple study designs
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significantly predicted carriage of antibiotic-resistant
pneumonia in young children, as reported in a commu-
nity study with 710 children that evaluated variables
such as household size, household income and limited
plumbing facilities [33].
Similar findings were obtained in Spain [34] when ana-
lysing 2726 bacterial isolates from clinical samples
submitted to the national reference laboratory, with
antibiotic-resistant S. pneumoniae more frequently iden-
tified in adults with less than primary school education.
A recent UK study also established that community-level
indicators of low adult education, skills and training, along
with poor living conditions, were two key domains
impacting on the prevalence of cefuroxime- and
nitrofurantoin-resistant E. coli [35].
Not all evidence in HICs, however, has established an
association between low educational level and antimicro-
bial resistance. In Sweden, adults with less than upper
secondary school education were no more likely to de-
velop antibiotic-resistant pneumonia, although total
prescribing of antibiotics was positively correlated with
per capita income (r = 0.597, P < 0.05) [25].
In LMICs, on the other hand, the educational level of
the population did not seem to have an impact on the
rates of antimicrobial resistance. In Indonesia, incom-
plete primary school education was not associated to
carriage of resistant E. coli [31]. Similar results have been
observed in rural India [36] and the Peruvian Amazon
[37]. Research on resistant Helicobacter pylori in
Bulgaria reported a negative association with educational
level [38]. In that study, where 266 consecutive H. pylori
strains isolated from untreated patients were evaluated
in 2004–2008, education was stratified as either ‘higher
education’ or ‘other’ without detailed definitions. Unlike
the other studies in LMICs, adult males with less than
primary school education in China were more likely to
be diagnosed with antibiotic-resistant gonorrhoea [32].
Water and sanitation
Clean water, safe and effective sanitation systems are
central to preventing diarrhoeal diseases. Therefore, the
burden of disease associated with poor water and sanita-
tion often has a greater effect on those living in poverty
in LMICs. Two papers explored the association between
water and sanitation and antimicrobial resistance in
LMICs, whilst no studies in HICs focused on these vari-
ables (Table 5).
Researchers in Brazil reported the wide distribution of
potentially pathogenic E. coli strains among asymptom-
atic children of low socioeconomic status [39]. In this
study, 79 school-age children between 5 and 10 years liv-
ing in a slum with no sewage system, occasional water
supply and infrequent domestic waste collection, were
matched with 35 children who attended a private school
of the same city. Resistance to either sulphonamides
(52%) or cotrimoxazole (35%) was more frequent in
cases from the slum (65%) than the control group (16%).
In India, the type of household water purification
method in two rural villages was associated with carriage
of resistant E. coli in primary school children [36]. Such
rates were determined from stool samples from primary
school children, and attendance to the local primary
school was used a substitute for the type of water purifi-
cation method used at these children’s homes.
Social deprivation
When investigating whether post-operative infection
with MRSA was associated with the socioeconomic
background of patients undergoing coronary artery by-
pass grafting in a London hospital over a 5-year period,
patient postcodes were linked according to social
deprivation demonstrating that citizens from most de-
prived neighbourhoods had a seven-fold higher infection
rate than those from the least deprived (Table 6) [40]. At
the time of the study it was not possible to determine
whether the results reflected a greater proportion of
MRSA carriers living in the most deprived areas, or in-
creased patient susceptibility to MRSA infection among
those more socially deprived.
Another study used surveillance data of urinary E. coli
isolates collected from patients attending primary care
services in England with suspected urinary tract infec-
tion in 2010–2012 [35]. The multilevel logistic regres-
sion models estimated that participants’ living
environment and residency in the most deprived areas
was associated with increased odds of antibiotic
Table 5 Studies identified exploring relation between antimicrobial resistance, water and sanitation
Authors
and year
Country Study
design
Participants Population Measurement
level of
poverty
Microorganism Colonisation/
infection
Association
with AMR
ICROMS
score
Souza et al.
2009 [39]
Brazil Case-
control
79 Children 5–10 years old
from the Colinas D’Oeste
slum
Household Resistant
Escherichia coli
Infection Positive Not
applicable
Seidman
et al. 2009
[36]
India Cross-
sectional
120 2 rural villages in Tamil
Nadu
Community Resistant
Escherichia coli
Colonisation Positive Not
applicable
AMR Antimicrobial resistance, ICROMS Integrated quality criteria for review of multiple study designs
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resistance in the isolates (OR = 1.33 [95% CI: 1.07–1.75]
–2.47 [95% CI: 1.08–5.66]) for different antibiotics.
In the UK again, a negative association was found when
exploring the potential link between socioeconomic status
as measured by the Jarman score, and resistance to metro-
nidazole (P = 0.95) or a macrolide (P = 0.31) in a cohort of
1064 patients undergoing endoscopy between 1994 and
1999 [41].
Discussion
This review examined the association between dimen-
sions of poverty and carriage or infection with
antimicrobial-resistant microorganisms. The variety of
poverty dimensions identified were reported based on
socioeconomic status, generally ascertained via proxy in-
dicators, geographical or census information. The lim-
ited number of papers identified had low to moderate
methodological quality and were predominantly con-
ducted in high income countries. Despite the heterogen-
eity of the studies, the results suggest an association
between a range of dimensions of poverty and
antimicrobial-resistant infections across all countries.
We identified a total of 19 studies, yet only four expli-
citly examined the association of poverty and AMR, sug-
gesting a need for further studies. Level of education,
low income, housing conditions, water and sanitation
were positively associated with AMR. Among the studies
in HICs, positive associations were identified between
housing conditions, lack of education and low income,
while in turn water and sanitation were positively associ-
ated with AMR in LMICs. Although there were differ-
ences in the strength of the relation across the
dimensions of poverty, intermediate determinants such
as level of income, level of education and housing
conditions exhibited a relatively consistent association
with AMR. The methodologies employed did not how-
ever allow for analysis of the mediating factors which
may explain these observations. For example, the extent
to which factors influencing health-seeking behaviours
are individual capacity issues and those that arise from
structural aspects, such as disparities in insurance pack-
ages available.
In terms of pathogens, the material dimensions of pov-
erty (housing, living conditions, social deprivation)
seemed to be associated with the carriage or infection
with resistant S. aureus. Perhaps this is not surprising,
considering characteristics of the organism such as per-
sistence in clinical and community environments [42],
with obvious importance to mitigate its transmission
and acquisition [43]. On the other hand, in the case of
infections with S. pneumoniae, the differing results ob-
tained by Jouirdain et a. (2010) [44] and Nilsson et al.
[25] may reflect increased exposure to antibiotics, even
in a high-income country as Belgium, and as also seen
in similar settings [45].
Although the association of education with resistance
in E. coli appeared to be equally present and absent,
such discrepancy may again reflect the diverse effect of
material dimensions of poverty such as housing condi-
tions including sanitation facilities –likely to be the case
in the study by Seidman et al. [36] or the effect of in-
creased exposure to antimicrobials [35] or lack of expos-
ure to them [31, 37].
The variability of results obtained in the E. coli studies
exemplifies well the careful equilibrium that societies
and health systems have to achieve and sustain between
reducing the likelihood of infection with resistant organ-
isms due to lack of material resources versus similar
Table 6 Studies identified exploring relation between antimicrobial resistance, social deprivation
Authors
and
year
Country Study design Participants Population Measurement
level of
poverty
Microorganism Colonisation
/infection
Association
with AMR
ICROMS
score
Duerink
et al.
2007
[31]
Indonesia Retrospective
data analysis
3275 Patients from 2 hospitals
and 3 primary health
centres in 2 cities in
Java
Household Resistant
Escherichia coli
Colonisation Negative Not
applicable
Nilsson
and
Laurell
2005
Sweden Retrospective
data analysis
766 Residents from Malmö Community Penicillin non-
susceptible
Staphylococcus
pneumoniae
Not
specified
Negative Not
applicable
Bagger
et al.
2004
[40]
UK Cohort 1739 UK residents undergoing
isolated coronary artery
bypass graft in 1
London hospital
Community MRSA Infection Positive 21
Parsons
et al.
2001
[41]
UK Cohort 1064 Patients from 1 hospital
in Sheffield
Community Resistant
Helicobacter
pylori
Not
specified
Negative 17
AMR Antimicrobial resistance, ICROMS Integrated quality criteria for review of multiple study designs, MRSA Methicillin-resistant Staphylococcus aureus
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infections resulting from excessive use of antibiotics. Fu-
ture studies considering the effect of socioeconomic de-
terminants on infections and drug-resistant organisms
may benefit from increasing the objective as well as sub-
jective precision used to establish individual, household
and community poverty. Additionally, it may be ex-
tremely useful to examine the effect of rapid transitions
away from deprivation (for example, due to gentrifica-
tion [46]) or towards poverty (for instance, as a result of
the recent financial crash and subsequent austerity mea-
sures [47]).
Colonisation or infection with resistant pathogens may
affect any group in society over lifetime, however vulner-
ability due to poverty may increase such risk.
Socio-economic deprivation in housing, environment
and work affects however the relationship between
health and ill health from utero to older age [48]. The
World Health Organization’s report on the social deter-
minants of health emphasised actions that eradicate pov-
erty and enhance opportunities for health and well-being
[49]. Health inequalities place individuals or populations
already vulnerable at a further disadvantage in terms of
infections. Consultations fees or the price of antimicro-
bials may push the poorest citizens to likely suboptimal
antimicrobials. Additionally, these same patients may be
offered consultations of poorer quality in terms of infor-
mation and involvement, when compared to other
groups [50]. The information shortcomings and disem-
powerment, coupled with health literacy deficits fuelled
by shared dimensions of poverty [51] are likely to impact
on perceptions and understanding of antimicrobials [52]
and reinforce subsequent inappropriate use.
Globally, sustaining finance and leadership have been
identified as key to achieving access while preventing ex-
cess of antimicrobial use [53]. Whilst good access to and
utilisation of health services is associated with equitable
health care, for low and middle income countries the is-
sues of clean water and sanitation, lack of infrastructure
and access to vaccines which result in repeated infec-
tions and antimicrobial use, possibly contributing to the
burden of antimicrobial resistance in these settings [54],
will have to be resolved in parallel to empowering citi-
zens to improve health seeking behaviours and attitudes
towards antimicrobial use.
This review has several limitations. We focussed on
published peer-reviewed journal articles and therefore
excluded grey literature. The studies extracted from this
review originated from eleven countries, therefore limit-
ing generalisation to other countries, LMICs particularly.
Considering a likely ascertainment bias (i.e., antimicro-
bial susceptibility testing and reporting much less fre-
quently available in LMICs) and the geographical
gradient for some pathogens (e.g. Acinetobacter) [55],
such under-representation of LMICs may be even more
threatening to any generalisability considerations. Meth-
odological difficulties inherent to the use of aggregate
scores to measure poverty create difficulty in distin-
guishing the dimensions of poverty with the greatest im-
pact on AMR. Further, most studies included were of
low to moderate quality, although the ICROMS tool
may appear to be applicable to only a few study designs.
Finally, publication bias may limit the conclusions
drawn.
Conclusions
These studies, despite methodological and qualitative
limitations, elicited the influence of dimensions of pov-
erty compounding AMR. Assumptions are often made
of the pathway leading dispossessed citizens with low in-
come, or living in poor communities, to develop anti-
biotic resistant infections. Whilst the association
between colonization or infection with drug-resistant or-
ganisms and socioeconomic factors, particularly poor
living conditions, poor sanitation, low level education or
health literacy and low income requires further research,
addressing the social determinants of poverty across na-
tional policies worldwide may remain a crucial yet
neglected step towards preventing antimicrobial
resistance.
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